BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7629877)

  • 1. Seasonal variation in melanoma progress.
    Akslen LA
    J Natl Cancer Inst; 1995 Jul; 87(13):1025-6. PubMed ID: 7629877
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural course of untreated cutaneous melanoma.
    Ahlgrimm-Siess V; Massone C; Hofmann-Wellenhof R; Kerl H
    Dermatol Surg; 2008 Mar; 34(3):371-3. PubMed ID: 18177394
    [No Abstract]   [Full Text] [Related]  

  • 3. Objective melanoma progression.
    Rubegni P; Burroni M; Nami N; Cevenini G; Bono R; Sbano P; Fimiani M
    Skin Res Technol; 2011 Feb; 17(1):69-74. PubMed ID: 20923468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrins and melanoma progression.
    Danen EH; van Muijen GN; ten Berge PJ; Ruiter DJ
    Recent Results Cancer Res; 1993; 128():119-32. PubMed ID: 8356314
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic progression of metastatic melanoma.
    Rodolfo M; Daniotti M; Vallacchi V
    Cancer Lett; 2004 Oct; 214(2):133-47. PubMed ID: 15363539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function association of tissue inhibitor of metalloproteinase-1 and malignant melanoma: systomics approach.
    Wiwanitkit V
    Acta Dermatovenerol Croat; 2010; 18(1):68. PubMed ID: 20361890
    [No Abstract]   [Full Text] [Related]  

  • 7. A Wnt-er wonderland--the complexity of Wnt signaling in melanoma.
    Weeraratna AT
    Cancer Metastasis Rev; 2005 Jun; 24(2):237-50. PubMed ID: 15986134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the lesions learned from the study of malignant melanoma be extrapolated to other cutaneous neoplasms?
    Maize JC
    Am J Dermatopathol; 1986 Apr; 8(2):93-4. PubMed ID: 3717527
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance.
    Campioni M; Santini D; Tonini G; Murace R; Dragonetti E; Spugnini EP; Baldi A
    Exp Dermatol; 2005 Nov; 14(11):811-8. PubMed ID: 16232302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic models for melanoma.
    Elder DE
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():68-75. PubMed ID: 20482678
    [No Abstract]   [Full Text] [Related]  

  • 11. Loss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression.
    Snedecor ER; Sung CC; Moncayo A; Rothstein BE; Mockler DC; Tonnesen MG; Jones EC; Fujita M; Clark RA; Shroyer KR; Chen J
    J Invest Dermatol; 2015 May; 135(5):1456-1458. PubMed ID: 25629424
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanoma stem cells--are there devils in the detail?
    Shackleton M
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):693-4. PubMed ID: 20704685
    [No Abstract]   [Full Text] [Related]  

  • 13. [The significance of skin adnexa in the primary proliferation of maligant melanoma].
    Herzberg JJ
    Arch Klin Exp Dermatol; 1967 Aug; 229(3):248-55. PubMed ID: 5593414
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse cutaneous melanosis in malignant melanoma.
    Paulo Filho Tde A; da Trindade Neto PB; Reis JC; Bartelt L; da Costa SA
    Dermatol Online J; 2007 May; 13(2):9. PubMed ID: 17498428
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant melanoma.
    Herrin HK
    Tex Dent J; 2001 Jun; 118(6):445-9. PubMed ID: 11484310
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of smoking in melanoma outcome still remains an enigma.
    Stadler R
    J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2219-2220. PubMed ID: 31779040
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypothesis: a role for telomere crisis in spontaneous regression of melanoma.
    Bastian BC
    Arch Dermatol; 2003 May; 139(5):667-8. PubMed ID: 12756110
    [No Abstract]   [Full Text] [Related]  

  • 18. Splenic weight determined by scintigraphy and skin reactivity test in patients with malignant melanoma.
    Front D; Mekori T; Yoselvsky G; Robinson E
    Nuklearmedizin; 1978 Apr; 17(2):74-5. PubMed ID: 662704
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant melanoma. The antecedent lesion--junction nevus?
    Brodkin RH
    J Med Soc N J; 1971 Sep; 68(9):703-5. PubMed ID: 5285950
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thermochemical explanation of hyperthermia due to malignant melanoma].
    Lintermans J; Maillard GF
    Arch Dermatol Forsch; 1971; 240(3):237-44. PubMed ID: 5578809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.